Mark T. Handley

1.4k total citations
15 papers, 559 citations indexed

About

Mark T. Handley is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Mark T. Handley has authored 15 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cell Biology and 5 papers in Physiology. Recurrent topics in Mark T. Handley's work include Cellular transport and secretion (8 papers), Erythrocyte Function and Pathophysiology (5 papers) and RNA modifications and cancer (3 papers). Mark T. Handley is often cited by papers focused on Cellular transport and secretion (8 papers), Erythrocyte Function and Pathophysiology (5 papers) and RNA modifications and cancer (3 papers). Mark T. Handley collaborates with scholars based in United Kingdom, United States and Japan. Mark T. Handley's co-authors include Robert D. Burgoyne, Irene A. Aligianis, Sarah M. Carpanini, Lee P. Haynes, Lee P. Haynes, Lu‐Yun Lian, Graham J. Dockray, Alan Morgan, Cédric Duval and Margaret E. Graham and has published in prestigious journals such as Nucleic Acids Research, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Mark T. Handley

14 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark T. Handley United Kingdom	12	302	297	89	83	62	15	559
Veronika Reiterer Switzerland	16	513 1.7×	308 1.0×	61 0.7×	124 1.5×	46 0.7×	22	816
Elena Sánchez-Heras United Kingdom	9	387 1.3×	242 0.8×	96 1.1×	55 0.7×	25 0.4×	9	583
Sreekumar Ramachandran United States	9	399 1.3×	299 1.0×	56 0.6×	41 0.5×	45 0.7×	15	549
Hiroaki Kajiho Japan	15	552 1.8×	422 1.4×	126 1.4×	49 0.6×	63 1.0×	24	880
Mónica Tomás Spain	15	308 1.0×	320 1.1×	73 0.8×	144 1.7×	25 0.4×	23	635
Federico Diez Argentina	11	434 1.4×	336 1.1×	181 2.0×	115 1.4×	115 1.9×	11	875
Anne‐Marie Haeberlé France	12	376 1.2×	190 0.6×	119 1.3×	59 0.7×	20 0.3×	20	511
Margaret M.P. Pearce United States	13	476 1.6×	353 1.2×	119 1.3×	192 2.3×	38 0.6×	17	758
Elena A. Matveeva United States	18	675 2.2×	408 1.4×	51 0.6×	239 2.9×	42 0.7×	29	888
Judith Wardwell-Swanson United States	10	242 0.8×	87 0.3×	47 0.5×	49 0.6×	53 0.9×	15	436

Countries citing papers authored by Mark T. Handley

Since Specialization

Citations

This map shows the geographic impact of Mark T. Handley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Handley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Handley more than expected).

Fields of papers citing papers by Mark T. Handley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Handley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Handley. The network helps show where Mark T. Handley may publish in the future.

Co-authorship network of co-authors of Mark T. Handley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Handley. A scholar is included among the top collaborators of Mark T. Handley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Handley. Mark T. Handley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mishra, Subodh Kumar, Mark T. Handley, Sweta Vangaveti, et al.. (2026). Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1. PubMed. 3(1). ugag007–ugag007.

Handley, Mark T., et al.. (2023). Inosine triphosphate pyrophosphatase: A guardian of the cellular nucleotide pool and potential mediator of RNA function. Wiley Interdisciplinary Reviews - RNA. 14(5). e1790–e1790. 4 indexed citations

Shorrock, Hannah K., Qishan Lin, Thomas J. Begley, et al.. (2022). Disease-associated inosine misincorporation into RNA hinders translation. Nucleic Acids Research. 50(16). 9306–9318. 10 indexed citations

Taylor, Rachel L., Mark T. Handley, Sarah Waller, et al.. (2017). Novel PEX11B Mutations Extend the Peroxisome Biogenesis Disorder 14B Phenotypic Spectrum and Underscore Congenital Cataract as an Early Feature. Investigative Ophthalmology & Visual Science. 58(1). 594–594. 24 indexed citations

Handley, Mark T., Sarah M. Carpanini, Girish R. Mali, et al.. (2015). Warburg Micro syndrome is caused by RAB18 deficiency or dysregulation. Open Biology. 5(6). 150047–150047. 33 indexed citations

Carpanini, Sarah M., Lisa McKie, Derek Thomson, et al.. (2014). A novel mouse model of Warburg Micro Syndrome reveals roles for RAB18 in eye development and organisation of the neuronal cytoskeleton. Disease Models & Mechanisms. 7(6). 711–22. 35 indexed citations

Handley, Mark T., André Mégarbané, Alison Meynert, et al.. (2014). Loss of ALDH18A1 function is associated with a cellular lipid droplet phenotype suggesting a link between autosomal recessive cutis laxa type 3A and Warburg Micro syndrome. Molecular Genetics & Genomic Medicine. 2(4). 319–325. 15 indexed citations

Gerondopoulos, Andreas, Ricardo Bastos, Shin‐ichiro Yoshimura, et al.. (2014). Rab18 and a Rab18 GEF complex are required for normal ER structure. The Journal of Cell Biology. 205(5). 707–720. 106 indexed citations

Handley, Mark T. & Irene A. Aligianis. (2012). RAB3GAP1, RAB3GAP2 and RAB18: disease genes in Micro and Martsolf syndromes. Biochemical Society Transactions. 40(6). 1394–1397. 23 indexed citations

10.

Handley, Mark T., Lu‐Yun Lian, Lee P. Haynes, & Robert D. Burgoyne. (2010). Structural and Functional Deficits in a Neuronal Calcium Sensor-1 Mutant Identified in a Case of Autistic Spectrum Disorder. PLoS ONE. 5(5). e10534–e10534. 61 indexed citations

11.

Burgoyne, Robert D., et al.. (2009). The Functions of Munc18‐1 in Regulated Exocytosis. Annals of the New York Academy of Sciences. 1152(1). 76–86. 42 indexed citations

12.

Handley, Mark T. & Robert D. Burgoyne. (2008). The Rab27 effector Rabphilin, unlike Granuphilin and Noc2, rapidly exchanges between secretory granules and cytosol in PC12 cells. Biochemical and Biophysical Research Communications. 373(2). 275–281. 18 indexed citations

13.

Handley, Mark T., Lee P. Haynes, & Robert D. Burgoyne. (2007). Differential dynamics of Rab3A and Rab27A on secretory granules. Journal of Cell Science. 120(6). 973–984. 57 indexed citations

14.

Graham, Margaret E., Mark T. Handley, Jeff W. Barclay, et al.. (2007). A gain-of-function mutant of Munc18-1 stimulates secretory granule recruitment and exocytosis and reveals a direct interaction of Munc18-1 with Rab3. Biochemical Journal. 409(2). 407–416. 49 indexed citations

15.

Duval, Cédric, et al.. (2005). Insulin-Like Growth Factor Binding Protein-5 Is a Target of Matrix Metalloproteinase-7: Implications for Epithelial-Mesenchymal Signaling. Cancer Research. 65(16). 7363–7369. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact